Amador Bioscience Completed The Acquisition Of Ann Arbor Pharmacometrics Group (A2Pg)
Dec 24, 2021•over 3 years ago
Acquiring Company
Amador Bioscience
Acquired Company
Ann Arbor Pharmacometrics Group
Description
Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that it has completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG), a premier pharmacometrics consulting firm based in Ann Arbor, Michigan.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed